Patent · US Active

System and method for cell type-specific translation of RNA molecules in eukaryotes

US12180470B2 · kind B2 · utility

0Cited by

7References

14Claims

0Family size

Assignee

SRTD BIOTECH GMBH · DE

Inventors

Heribert Bohlen · Cologne, DE
Bernd Hoffmann · Frankfurt am Main, DE

Key dates

Filing date	Feb 9, 2018
Grant date	Dec 31, 2024
Priority date	—
Expiry date	May 17, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/203
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present technology comprises methods and RNA constructs for the targeted translation of a polypeptide of interest in a eukaryotic target cell, and to the use thereof in therapeutic clinical applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.